Valuation: Episurf Medical AB

Capitalization 47.64M 5.06M 4.35M 4.09M 3.8M 7M 456M 7.64M 18.45M 215M 18.99M 18.58M 789M P/E ratio 2025 *
-
P/E ratio 2026 * -
Enterprise value 47.64M 5.06M 4.35M 4.09M 3.8M 7M 456M 7.64M 18.45M 215M 18.99M 18.58M 789M EV / Sales 2025 *
3.5x
EV / Sales 2026 * 1.88x
Free-Float
77.09%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.05%
1 week-2.77%
Current month-2.77%
1 month-7.87%
3 months-27.39%
6 months-73.93%
Current year-79.46%
More quotes
1 week 0.03
Extreme 0.0265
0.03
1 month 0.02
Extreme 0.0245
0.03
Current year 0.02
Extreme 0.0245
0.15
1 year 0.02
Extreme 0.0245
0.15
3 years 0.02
Extreme 0.0245
2.7
5 years 0.02
Extreme 0.0245
5.91
10 years 0.02
Extreme 0.0245
20.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2025-09-30
President 42 2020-12-31
Chief Executive Officer 42 2016-12-31
Director TitleAgeSince
Director/Board Member 76 2008-12-31
Director/Board Member 59 2016-04-30
Chairman 71 2023-05-03
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.09%-2.77%-80.35%-98.49% 5.06M
-2.67%-4.60%+6.29%+14.22% 217B
-0.28%-2.07%+20.53%+30.09% 130B
-0.48%-6.00%+40.74%+98.58% 65.89B
-1.74%-1.11%-14.94%-23.50% 55.36B
+0.10%+2.03%+17.94%+77.68% 52.03B
-0.42%+0.06%+21.99%+38.24% 25.84B
+0.03%+2.83%-16.69%-46.75% 25.54B
-0.84%+1.63%+14.73%-33.20% 24.14B
+0.02%-2.89%-23.07%+19.97% 22.48B
Average -0.52%-1.14%-1.28%+7.69% 61.87B
Weighted average by Cap. -1.23%-2.43%+11.00%+25.34%
See all sector performances

Financials

2025 *2026 *
Net sales 13.6M 1.44M 1.24M 1.17M 1.08M 2M 130M 2.18M 5.27M 61.47M 5.42M 5.3M 225M 25.4M 2.7M 2.32M 2.18M 2.03M 3.73M 243M 4.07M 9.84M 115M 10.12M 9.91M 421M
Net income -56.6M -6.01M -5.17M -4.86M -4.52M -8.32M -542M -9.08M -21.92M -256M -22.56M -22.08M -937M -43.5M -4.62M -3.98M -3.73M -3.47M -6.4M -416M -6.98M -16.84M -197M -17.34M -16.97M -720M
Net Debt - -
More financial data * Estimated data
Logo Episurf Medical AB
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
Employees
26
More about the company
Date Price Change Volume
25-12-08 0.0281 kr -2.09% 1,874,417
25-12-05 0.0287 kr +1.77% 2,921,374
25-12-04 0.0282 kr 0.00% 1,056,694
25-12-03 0.0282 kr +1.08% 5,709,201
25-12-02 0.0279 kr -3.46% 4,531,062

Delayed Quote Nasdaq Stockholm, December 08, 2025 at 12:00 pm

More quotes

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EPIS B Stock